These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18619)

  • 1. Renin profiles. The unfulfilled promises.
    Kaplan NM
    JAMA; 1977 Aug; 238(7):611-3. PubMed ID: 18619
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
    Laragh JH
    Am J Med; 1973 Sep; 55(3):261-74. PubMed ID: 4355699
    [No Abstract]   [Full Text] [Related]  

  • 3. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].
    Bühler FR
    Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL; Tarazi RC; Dustan HP
    N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
    Laragh JH
    Am J Med; 1976 Nov; 61(5):797-810. PubMed ID: 10730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of beta-blocking agents on blood pressure and plasma renin activity in experimental renovascular hypertension (author's transl)].
    Takata M; Shimao M; Uno D; Arai S; Takabatake T; Nomura G; Hattori N
    Nihon Jinzo Gakkai Shi; 1977 Nov; 19(11):921-8. PubMed ID: 24774
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
    Weinberger MH; Dowdy AJ; Nokes GW; Luetscher JA
    J Clin Endocrinol Metab; 1968 Mar; 28(3):359-71. PubMed ID: 5642688
    [No Abstract]   [Full Text] [Related]  

  • 8. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.
    Gavras H; Brunner HR; Laragh JH; Sealey JE; Gavras I; Vukovich RA
    N Engl J Med; 1974 Oct; 291(16):817-21. PubMed ID: 4371298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and unilateral parenchymal renal disease. Evidence for abnormal vasoconstriction-volume interaction.
    Vaughan ED; Bühler FR; Laragh JH; Sealey JE; Gavras H; Baer L
    JAMA; 1975 Sep; 233(11):1177-83. PubMed ID: 1174172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of hemodynamic findings in hypertension.
    Frohlich ED
    Chest; 1973 Jul; 64(1):94-9. PubMed ID: 4352167
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: When to measure renin.
    Lancet; 1975 Apr; 1(7910):783-4. PubMed ID: 48006
    [No Abstract]   [Full Text] [Related]  

  • 13. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
    Laragh JH
    Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renin-angiotensin-aldosterone system in hypertensive conditions].
    Weidmann P; Siegenthaler W
    Dtsch Med Wochenschr; 1967 Oct; 92(43):1953-61. PubMed ID: 6075886
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 16. Renovascular hypertension: a paradigm for all hypertension.
    Laragh JH
    J Hypertens Suppl; 1986 Oct; 4(4):S79-88. PubMed ID: 3534186
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L; Licata G; Sparacino V; Custro N; Indovina I
    Clin Ter; 1979 Aug; 90(3):223-32. PubMed ID: 45260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ambulant and stationary determination of the renin-sodium index in the classification and treatment of essential hypertension].
    Bühler FR; Patel U; Marbet G
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1802-5. PubMed ID: 4156423
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of chronic adrenergic receptor blockade on plasma renin activity in man.
    Michelakis AM; McAllister RG
    J Clin Endocrinol Metab; 1972 Feb; 34(2):386-94. PubMed ID: 4400632
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlations of the fibrinogen level with the blood pressure and with the plasma renin activity in hypertensive patients. Preliminary communication.
    Sonkodi S; Rednik A; Kovács A
    Cor Vasa; 1979; 21(3):228-232. PubMed ID: 394935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.